How Long Do Wegovy Symptoms Last — and When Does It Get Easier?

You've just taken your first or second injection, here's what's likely happening

Picture the scene: you're a few days post-injection, and nausea has arrived uninvited. It's Monday morning, you've just started treatment, and the timing (maybe right before a work trip or payday dinner plans) feels particularly inconvenient. The reassuring news is that this is the phase most people find hardest, and it is usually the shortest one.

Semaglutide, the active ingredient in Wegovy, slows gastric emptying as part of how it works. That slower passage of food through the stomach is largely responsible for the nausea, bloating, burping and feeling of fullness that many people experience early on. The first week of Wegovy tends to bring the most noticeable gut symptoms, simply because the body has had no time to acclimatise. For a significant portion of people, nausea becomes far less prominent by week two or three. Vomiting, diarrhoea and constipation follow a similar pattern, though the timing varies from person to person.

Fatigue and mild headaches also appear early for some. These tend to be short-lived, often linked to reduced food intake and the adjustment in blood sugar dynamics. Staying hydrated and eating smaller, lower-fat meals can take the edge off, something the NHS semaglutide guidance specifically recommends. Injection-site reactions (redness or a small lump where you injected) typically resolve within a day or two.

Dose increases restart the clock, but usually for a shorter time

Wegovy is titrated gradually: the starting dose is 0.25 mg, moving through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance level, with at least four weeks at each step. If you are working towards the newer 7.2 mg maximum, approved by the MHRA in early 2026, there are further steps beyond that. Each increase can bring a return of milder gut symptoms, usually for a shorter window than the very first adjustment period. Most people find the second or third dose increase barely noticeable once they know what to expect.

This reset pattern is worth understanding because it affects how you plan. The person three months into treatment who suddenly experiences nausea again after feeling perfectly comfortable is not going backwards, they have just stepped up to a new dose. That context matters. If you want a clearer sense of how long Wegovy takes to show results, the titration timeline is the same calendar to follow, and understanding how long Wegovy lasts between doses helps explain why side-effect windows and effectiveness windows are two sides of the same schedule.

The cost of treatment and how to access it legitimately are explored on our Wegovy treatment overview. For now, the practical point is that symptoms tied to dose increases are predictable enough to plan around, especially once you have been through the first adjustment once.

When symptoms go beyond the ordinary adjustment window

Most Wegovy side effects are mild to moderate and self-limiting. Some are neither. In January 2026, the MHRA issued a Drug Safety Update reinforcing guidance that acute pancreatitis (a serious inflammation of the pancreas) is a known but infrequent risk with GLP-1 medicines including semaglutide. The specific warning sign is severe stomach pain that does not pass and radiates toward the back, with or without vomiting. That is not part of ordinary adjustment; get medical help promptly. You can read the MHRA's broader guidance on the Yellow Card site, where you can also report any side effects you experience.

Gallbladder problems (including gallstones) have been reported with semaglutide, particularly with rapid weight loss. Upper-right abdominal pain, especially after eating fatty food, is the signal to mention to a doctor. Severe dehydration from persistent vomiting or diarrhoea can affect kidney function, so it should not be left untreated. And anyone who notices low mood, unusual thoughts, or changes in their mental wellbeing during treatment should contact their prescriber or GP directly. How long semaglutide stays active in the body after a dose is a related question with practical implications for how long these effects could persist if something goes wrong.

Symptoms that have not settled after three to four weeks at a stable dose, that feel disproportionately severe, or that are new and unexplained are always worth discussing with a clinician rather than waiting out. Our FAQs cover some common questions, and our prescribers are reachable for aftercare seven days a week.

Longer-term: what most people report after the first few months

By the time someone reaches and stabilises at their maintenance dose, the picture for most people is considerably more comfortable than those early weeks suggested it would be. Nausea becomes infrequent rather than routine. The gastrointestinal effects that were daily in week one might appear occasionally, usually when a meal is larger or richer than the body now prefers. That shift in appetite and portion tolerance is itself part of how the medicine works, and most people come to read it as a signal rather than a problem.

Some people do experience side effects that persist longer than average. Individual factors including gut motility, other medicines, and overall health play a role. If you are concerned that your experience is outside the normal range, it is worth checking whether Wegovy is still working as expected or whether a clinical review is due. Treatment should be reassessed regularly, that is part of responsible prescribing, not an afterthought.

If you are thinking about starting or are already mid-treatment and want clinical input on how your symptom experience compares, speak to our prescribers, every patient at nume has access to aftercare seven days a week, included in the price of treatment.